Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1242, 2000-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rivastigmine slows AD and cuts costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 267, 2000-01 ,pp. :
Memantine cuts costs of AD for patients, caregivers
Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. :
Memantine improves outlook, cuts healthcare costs in AD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. :
Memantine improves outlook, cuts healthcare costs in AD
Inpharma, Vol. 1, Iss. 1397, 2003-01 ,pp. :
Memantine cuts costs of AD for patients, caregivers
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. :